High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$1.1M
$1,053,680
Total Sells (Filtered)
$62.5M
$62,543,787
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| HTFL |
Heartflow, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-04-01 | $2,424 | M | Form 4 |
|
HTFL
S
Heartflow, Inc.
Rogers Campbell
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -44.3%
2026-04-01
$1,590,093Large
|
||||||
| HTFL |
Heartflow, Inc.
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -44.3%
|
2026-04-01 | $1,590,093Large | S | Form 4 |
| HTFL |
Heartflow, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-04-01 | $15,205 | M | Form 4 |
| HTFL |
Heartflow, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-04-01 | $90,501 | M | Form 4 |
| HTFL |
Heartflow, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-04-01 | $42,426 | M | Form 4 |
| HTFL |
Heartflow, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-03-19 | $43,072 | M | Form 4 |
|
HTFL
S
Heartflow, Inc.
Rogers Campbell
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -45.1%
2026-03-19
$1,658,033Large
|
||||||
| HTFL |
Heartflow, Inc.
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -45.1%
|
2026-03-19 | $1,658,033Large | S | Form 4 |
| HTFL |
Heartflow, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-03-19 | $105,705 | M | Form 4 |
| HTFL |
Heartflow, Inc.
|
CEO
10b5-1 Sell
|
2026-03-18 | $243,125 | S | Form 4 |
| HTFL |
Heartflow, Inc.
|
Director
Other
|
2026-03-11 | $19,241 | M | Form 4 |
| HTFL |
Heartflow, Inc.
|
CEO
10b5-1 Sell
|
2026-03-10 | $290,886 | S | Form 4 |
| HTFL |
Heartflow, Inc.
|
Director
10b5-1 SellΔOwn -25.1%
|
2026-03-05 | $228,050 | S | Form 4 |
| HTFL |
Heartflow, Inc.
|
Director
Other
|
2026-02-17 | $20,800 | M | Form 4 |
| HTFL |
Heartflow, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-02-12 | $43,070 | M | Form 4 |
|
HTFL
S
Heartflow, Inc.
Rogers Campbell
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -46.1%
2026-02-12
$1,595,486Large
|
||||||
| HTFL |
Heartflow, Inc.
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -46.1%
|
2026-02-12 | $1,595,486Large | S | Form 4 |
| HTFL |
Heartflow, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-02-12 | $17,551 | M | Form 4 |
| HTFL |
Heartflow, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-02-12 | $330,776 | M | Form 4 |
| HTFL |
Heartflow, Inc.
|
CEO
10b5-1 Sell
|
2026-02-10 | $619,553 | S | Form 4 |
| HTFL |
Heartflow, Inc.
|
Director
10b5-1 SellΔOwn -18.0%
|
2026-02-05 | $218,560 | S | Form 4 |
|
HTFL
S
Heartflow, Inc.
Bain Capital Life Sciences Investors, LLC
• 10% Owner
Discretionary SellΔOwn -16.1%
2026-02-04
$56,100,000MEGA
|
||||||
| HTFL |
Heartflow, Inc.
|
10% Owner
Discretionary SellΔOwn -16.1%
|
2026-02-04 | $56,100,000MEGA | S | Form 4 |
| HTFL |
Heartflow, Inc.
|
Director
Discretionary Buy
|
2025-12-16 | $1,053,680Large | P | Form 4 |